Get the Stockscreener App
4.11
5.95%
-0.26
After Hours:
4.30
0.19
+4.62%
Zura Bio Ltd stock is traded at $4.11, with a volume of 423.13K.
It is down -5.95% in the last 24 hours and down -6.16% over the past month.
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
See More
Previous Close:
$4.37
Open:
$4.27
24h Volume:
423.13K
Relative Volume:
1.00
Market Cap:
$278.69M
Revenue:
-
Net Income/Loss:
$-60.36M
P/E Ratio:
-0.9815
EPS:
-4.1875
Net Cash Flow:
$-15.05M
1W Performance:
-8.26%
1M Performance:
-6.16%
6M Performance:
-11.04%
1Y Performance:
-15.78%
1-Day Range:
$4.00
$4.42
1-Week Range:
$4.00
$4.82
52-Week Range:
$2.00
$6.35
Zura Bio Ltd Stock (ZURA) Company Profile
Name
Zura Bio Ltd
Sector
Industry
Phone
858-247-0520
Address
4225 EXECUTIVE SQUARE, LA JOLLA
Zura Bio Ltd Stock (ZURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-23 | Initiated | Oppenheimer | Outperform |
| Jun-22-23 | Initiated | Guggenheim | Buy |
| Jun-14-23 | Initiated | Chardan Capital Markets | Buy |
| May-24-23 | Initiated | Raymond James | Strong Buy |
Zura Bio Ltd Stock (ZURA) Latest News
Piper Sandler sets price target on Zura Bio shares, cites positive trial data - Investing.com
Leerink Partners initiates Zura Bio stock with Outperform rating, $15 target - Investing.com
Zura Bio Ltd re-elects board, ratifies auditor at AGM By Investing.com - Investing.com Australia
Zura Bio to Participate in Two Upcoming Investor Conferences in November - Yahoo Finance
Zura Bio Ltd re-elects board, ratifies auditor at AGM - Investing.com India
Zura Bio announces departure of Chief Scientific Officer By Investing.com - Investing.com Australia
Zura Bio announces departure of Chief Scientific Officer - Investing.com India
Private equity firms among Zura Bio Limited's (NASDAQ:ZURA) largest shareholders, saw gain in holdings value after stock jumped 14% last week - Simply Wall St
Bullish Zura Bio Insiders Loaded Up On US$1.01m Of Stock - Yahoo Finance
Forefront Analytics LLC Has $145,000 Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World
Zura Bio Limited (NASDAQ:ZURA) Shares Sold by Affinity Asset Advisors LLC - Defense World
Should investors be concerned about Zura Bio Ltd (ZURA)? - US Post News
A stock that deserves closer examination: Zura Bio Ltd (ZURA) - US Post News
Institutions profited after Zura Bio Limited's (NASDAQ:ZURA) market cap rose US$45m last week but private equity firms profited the most - Yahoo Finance
Piper Sandler maintains Overweight rating on Zura Bio shares - Investing.com
Zura Bio Ltd [ZURA] Director makes an insider sale of 3,800,000 shares worth 10,260,000. - Knox Daily
Piper Sandler maintains Overweight rating on Zura Bio shares By Investing.com - Investing.com Australia
Zura Bio Ltd (ZURA) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
Zura Bio (NASDAQ:ZURA) versus Aligos Therapeutics (NASDAQ:ALGS) Critical Comparison - Defense World
A Guide To The Risks Of Investing In Zura Bio Ltd (ZURA) - Knox Daily
Have Zura Bio Insiders Been Selling Stock? - Simply Wall St
Zura Bio director Sidhu Someit sells shares worth over $200,000 - Investing.com
Taking a look at what insiders are doing to gauge the Zura Bio Ltd (ZURA)’s direction - Knox Daily
Zura Bio to Present at Three Upcoming Investor Conferences in September - Yahoo Finance
Zura Bio Ltd [ZURA] Stock bought by Insider Ploos van Amstel Arnout for $0.5 million - Knox Daily
Get in on Zura Bio Ltd’s (ZURA) buy-in window today! - SETE News
Zura Bio Ltd (ZURA) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Zura Bio issues warrants after share surrender - Investing.com India
Zura Bio Ltd [ZURA] Investment Guide: What You Need to Know - Knox Daily
Chardan Capital Comments on Zura Bio Limited’s FY2024 Earnings (NASDAQ:ZURA) - Defense World
Cantor Fitzgerald Reiterates Overweight Rating for Zura Bio (NASDAQ:ZURA) - Defense World
Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Lelezard
Zura Bio Limited (NASDAQ:ZURA) Sees Significant Increase in Short Interest - Defense World
Zura Bio Completes Exchange Offer and Consent Solicitation and Notice to Exercise Right to Exchange Remaining Outstanding Warrants - Yahoo Finance
Trading Day Triumph: Zura Bio Ltd (ZURA) Ends at 3.39, a -4.24 Surge/Plunge - The Dwinnex
Zura Bio Limited (NASDAQ:ZURA) Given Consensus Rating of “Buy” by Analysts - Defense World
Zura Bio Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to its Warrants - Yahoo Finance
Insider Buyers At Zura Bio Likely Disappointed With 11% Slide - Simply Wall St
Investing in Zura Bio Ltd (ZURA): What You Must Know - Knox Daily
Zura Bio Names Robert Lisicki As CEO & Director Of The Board - Contract Pharma
Zura Bio Ltd (ZURA) rating initates by Piper Sandler - Knox Daily
Zura Bio Limited (NASDAQ:ZURA) Short Interest Up 152.1% in July - Defense World
Zura Bio Ltd reaches settlement with former CEO - Investing.com India
Zura Bio Ltd reaches settlement with former CEO By Investing.com - Investing.com Canada
Stocks of Zura Bio Ltd (ZURA) are poised to climb above their peers - SETE News
Investor’s Toolkit: Key Ratios for Assessing Zura Bio Ltd (ZURA)’s Performance - The Dwinnex
Zura Bio Ltd (ZURA)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Zura Bio Ltd [ZURA] Records 50-Day SMA of $4.28 - Knox Daily
Zura Bio Limited (NASDAQ:ZURA) Receives Average Recommendation of “Buy” from Brokerages - Defense World
British Land Company PLC (LON:BLND) Given Consensus Rating of “Hold” by Brokerages - Defense World
Piper Sandler gives an Overweight recommendation for Zura Bio Ltd (ZURA) - Knox Daily
Zura Bio Ltd Stock (ZURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zura Bio Ltd Stock (ZURA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sidhu Someit | Director |
Sep 04 '24 |
Sale |
3.87 |
51,728 |
200,187 |
2,085,418 |
2.02%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):